CLINICAL_TRIALS
withdrawal
· 2026-01-22
Clinical Trial Update: Terbutaline Sulfate in Adults With Asthma [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 clinical trial evaluating terbutaline sulfate in adults with asthma has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kanecia Obie Zimmerman | Conditions: Asthma | Phase 2, Phase 3 | Status: WITHDRAWN